SMT201600217B - Furancarbossamidi sostituite e loro uso - Google Patents
Furancarbossamidi sostituite e loro usoInfo
- Publication number
- SMT201600217B SMT201600217B SM201600217T SM201600217T SMT201600217B SM T201600217 B SMT201600217 B SM T201600217B SM 201600217 T SM201600217 T SM 201600217T SM 201600217 T SM201600217 T SM 201600217T SM T201600217 B SMT201600217 B SM T201600217B
- Authority
- SM
- San Marino
- Prior art keywords
- furancarbossamids
- substituted
- furancarbossamids substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008062878A DE102008062878A1 (de) | 2008-12-17 | 2008-12-17 | Substituierte Furancarboxamide und ihre Verwendung |
| PCT/EP2009/008978 WO2010075957A1 (de) | 2008-12-17 | 2009-12-16 | Substituierte furancarboxamide und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201600217B true SMT201600217B (it) | 2016-08-31 |
Family
ID=41796256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201600217T SMT201600217B (it) | 2008-12-17 | 2016-07-05 | Furancarbossamidi sostituite e loro uso |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8324268B2 (it) |
| EP (1) | EP2376479B1 (it) |
| CA (1) | CA2747640A1 (it) |
| CY (1) | CY1117577T1 (it) |
| DE (1) | DE102008062878A1 (it) |
| DK (1) | DK2376479T3 (it) |
| ES (1) | ES2574639T3 (it) |
| HR (1) | HRP20160578T1 (it) |
| HU (1) | HUE027605T2 (it) |
| PL (1) | PL2376479T3 (it) |
| PT (1) | PT2376479E (it) |
| SI (1) | SI2376479T1 (it) |
| SM (1) | SMT201600217B (it) |
| WO (1) | WO2010075957A1 (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007336781C1 (en) * | 2006-12-21 | 2014-10-09 | Sloan-Kettering Institute For Cancer Research | Pyridazinones and furan-containing compounds |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| EP3827006A4 (en) | 2018-07-23 | 2022-04-06 | Signalrx Pharmaceuticals, Inc. | SINGLE-MOLECULE COMPOUNDS WITH MULTI-TARGET INHIBITION OF BTK AND OTHER PROTEINS AND METHODS OF USE THEREOF |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3806506A (en) * | 1971-08-05 | 1974-04-23 | Uniroyal Inc | Furan derivatives,compositions thereof and methods for using same |
| DE3119796A1 (de) | 1981-05-19 | 1982-12-23 | Hoechst Ag, 6000 Frankfurt | Substituierte tryptaminderivate von thienyloxpropanolaminen, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen sowie ihre verwendung |
| FR2538388B1 (fr) | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| IL91418A (en) | 1988-09-01 | 1997-11-20 | Rhone Poulenc Agrochimie | (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them |
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| US5571810A (en) * | 1990-06-11 | 1996-11-05 | Fujisawa Pharmaceutical Co., Ltd. | Thiophene derivatives |
| GB9012936D0 (en) | 1990-06-11 | 1990-08-01 | Fujisawa Pharmaceutical Co | Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| IL104311A (en) | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| JPH084281B2 (ja) | 1992-09-30 | 1996-01-17 | 橋本コーポレイション株式会社 | オンフック後相手の声を拡声する電話装置 |
| FR2728571B1 (fr) | 1994-12-22 | 1997-01-31 | Adir | Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| US5696151A (en) * | 1995-11-30 | 1997-12-09 | Uniroyal Chemical Company, Inc. | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
| US6143780A (en) * | 1999-09-17 | 2000-11-07 | Uniroyal Chemical Company, Inc. | N-arylmethylthioanilide compounds useful for the inhibition of the replication of HIV |
| NZ522696A (en) | 2000-06-28 | 2004-08-27 | Astrazeneca Ab | Substituted quinazoline derivatives and their use as inhibitors |
| GB0113524D0 (en) | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
| WO2003014107A1 (en) | 2001-08-01 | 2003-02-20 | Basell Polyolefine Gmbh | Process for the preparation of heterocyclic pentalene derivatives |
| DE60235114D1 (de) | 2001-11-01 | 2010-03-04 | Icagen Inc | Pyrazolamide zur anwendung in der behandlung von schmerz |
| AU2003265395A1 (en) | 2002-08-14 | 2004-03-03 | Ppd Discovery, Inc. | Prenylation inhibitors and methods of their synthesis and use |
| GB0221477D0 (en) | 2002-09-16 | 2002-10-23 | Pfizer Ltd | Chemical compounds |
| GB0223232D0 (en) | 2002-10-07 | 2002-11-13 | Pfizer Ltd | Chemical compounds |
| ATE334687T1 (de) * | 2002-11-20 | 2006-08-15 | Paradigm Therapeutics Ltd | Heterozyklische siliziumverbindungen und deren verwendung zur behandlung von krankheiten oder zuständen, die mit gonadotropin-freisetzenden hormon assoziiert sind |
| JP4419078B2 (ja) | 2002-12-02 | 2010-02-24 | アステラス製薬株式会社 | ピラゾール誘導体 |
| PL377848A1 (pl) | 2003-02-07 | 2006-02-20 | Daiichi Pharmaceutical Co., Ltd. | Pochodne pirazoli |
| EP1599476B1 (en) | 2003-02-27 | 2009-10-14 | Neurosearch A/S | Novel diazabicyclic aryl derivatives |
| FR2856683A1 (fr) | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
| GB0315657D0 (en) | 2003-07-03 | 2003-08-13 | Astex Technology Ltd | Pharmaceutical compounds |
| US20050026968A1 (en) | 2003-07-14 | 2005-02-03 | University Of Tennessee Research Foundation | Heterocyclic amides with anti-tuberculosis activity |
| US7220772B2 (en) | 2003-09-05 | 2007-05-22 | Pfizer, Inc. | Pyrazole derivatives |
| FR2860792B1 (fr) | 2003-10-10 | 2006-02-24 | Sanofi Synthelabo | Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique |
| BRPI0507786A (pt) | 2004-02-20 | 2007-07-17 | Astrazeneca Ab | composto e sais farmaceuticamente aceitáveis do mesmo, formulação farmacêutica, uso de um composto, método de tratar uma doença, e, processo para a preparação de compostos |
| RU2007103831A (ru) | 2004-07-01 | 2008-08-10 | Дайити Фармасьютикал Ко., Лтд. (JP) | Производные пиразола |
| GB0417910D0 (en) | 2004-08-11 | 2004-09-15 | Novartis Ag | Organic compounds |
| US7705025B2 (en) | 2004-08-23 | 2010-04-27 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
| DE102004054666A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| JP2008523072A (ja) | 2004-12-07 | 2008-07-03 | ルーカス ファーマシューティカルズ， インコーポレイテッド | タンパク質キナーゼの阻害剤 |
| CA2589271A1 (en) | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
| EP1831231A1 (en) | 2004-12-15 | 2007-09-12 | AstraZeneca AB | Nicotinic acetylcholine receptor ligands |
| WO2006099231A1 (en) | 2005-03-10 | 2006-09-21 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives for treatment of hyperproliferative disorders |
| WO2007002563A1 (en) | 2005-06-27 | 2007-01-04 | Exelixis, Inc. | Imidazole based lxr modulators |
| WO2007009701A2 (en) | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| EP1743637A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| GB0516661D0 (en) | 2005-08-13 | 2005-09-21 | Astrazeneca Ab | Therapeutic agents |
| EP2091942B1 (en) | 2006-10-12 | 2010-02-17 | Janssen Pharmaceutica N.V. | Substituted pyrazinone derivatives for use as a medicine |
| AU2007336781C1 (en) | 2006-12-21 | 2014-10-09 | Sloan-Kettering Institute For Cancer Research | Pyridazinones and furan-containing compounds |
| GB0701426D0 (en) | 2007-01-25 | 2007-03-07 | Univ Sheffield | Compounds and their use |
| DE102008015033A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008015032A1 (de) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
-
2008
- 2008-12-17 DE DE102008062878A patent/DE102008062878A1/de not_active Ceased
-
2009
- 2009-12-16 WO PCT/EP2009/008978 patent/WO2010075957A1/de not_active Ceased
- 2009-12-16 EP EP09803727.8A patent/EP2376479B1/de active Active
- 2009-12-16 HR HRP20160578TT patent/HRP20160578T1/hr unknown
- 2009-12-16 SI SI200931445A patent/SI2376479T1/sl unknown
- 2009-12-16 ES ES09803727.8T patent/ES2574639T3/es active Active
- 2009-12-16 PL PL09803727.8T patent/PL2376479T3/pl unknown
- 2009-12-16 PT PT09803727T patent/PT2376479E/pt unknown
- 2009-12-16 HU HUE09803727A patent/HUE027605T2/en unknown
- 2009-12-16 DK DK09803727.8T patent/DK2376479T3/en active
- 2009-12-16 CA CA2747640A patent/CA2747640A1/en not_active Abandoned
-
2011
- 2011-06-16 US US13/162,521 patent/US8324268B2/en not_active Expired - Fee Related
-
2016
- 2016-05-31 CY CY20161100476T patent/CY1117577T1/el unknown
- 2016-07-05 SM SM201600217T patent/SMT201600217B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8324268B2 (en) | 2012-12-04 |
| WO2010075957A1 (de) | 2010-07-08 |
| DK2376479T3 (en) | 2016-06-13 |
| PL2376479T3 (pl) | 2016-09-30 |
| PT2376479E (pt) | 2016-06-07 |
| ES2574639T3 (es) | 2016-06-21 |
| CA2747640A1 (en) | 2010-07-08 |
| CY1117577T1 (el) | 2017-04-26 |
| DE102008062878A1 (de) | 2010-06-24 |
| EP2376479B1 (de) | 2016-03-02 |
| EP2376479A1 (de) | 2011-10-19 |
| SI2376479T1 (sl) | 2016-07-29 |
| US20120022059A1 (en) | 2012-01-26 |
| HRP20160578T1 (hr) | 2016-07-15 |
| HUE027605T2 (en) | 2016-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201500218B (it) | Composti aril-fenil-solfonammido-cicloalchile e loro uso | |
| SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
| BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
| BRPI0821668A2 (pt) | Uso | |
| HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
| BR112012002349A2 (pt) | composto,e, uso do mesmo | |
| BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
| BRPI1007494A2 (pt) | composto e uso do mesmo | |
| SMT201600226B (it) | Alcune amminopirimidine, loro composizioni e metodi per il loro uso | |
| SMP200900082B (it) | Composti organici e loro utilizzazione | |
| SMT201500120B (it) | Agenti di legame di notch e antagonisti di notch emetodi per il loro uso | |
| SMT201500213B (it) | Alcune triazolopirazine, loro composizioni e metodi d'uso | |
| DOP2010000260A (es) | Derivado heterociclico fusionado y su uso | |
| CR20130360A (es) | Compuesto heterocíclico y su uso | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| BRPI0906478A2 (pt) | anticorpo anti-nr10 e uso do mesmo | |
| BRPI0914536A2 (pt) | tiadiazoliloxifenilamidinas e o uso destas como fungicidas | |
| BRPI0915086A2 (pt) | detecção do uso de canabis | |
| DK2252395T3 (da) | Afsvovlingsmaterialer | |
| BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
| BRPI0823082A2 (pt) | Uso derivados de sesquiterpeno | |
| BRPI0913945A2 (pt) | agentes anti-inflamatórios | |
| BRPI0907365A2 (pt) | Composição antimicrobiana e uso | |
| BRPI1006996A2 (pt) | composição, método e uso | |
| SMT201500273B (it) | Diidroetorfine e loro preparazione |